BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, February 5, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 19, 1999

View Archived Issues

New mediator of allergic asthma revealed in studies using interleukin-13 fusion protein

Read More

AMPA antagonists and their use described by Pfizer

Read More

Tricyclic antiproliferative agents revealed by Schering-Plough

Read More

Cancer Research Campaign Technology evaluates new antitumor trimelamol analogues

Read More

New broad-spectrum antibacterial series patented by Bayer

Read More

Cyanoenamines as potassium channel modulators

Read More

Roche presents new compound for hyperproliferative skin disorders

Read More

Licensing opportunity announced: liposomal compound for treatment of ARDS

Read More

AstraZeneca merger proceedings under way

Read More

New indication approved for Livial, a tissue-specific treatment for menopausal symptoms

Read More

Results from large study comparing atovaquone and dapsone for PCP prophylaxis published

Read More

Different concentrations of olopatadine compared to placebo for preventing allergic conjunctivitis

Read More

Z-335 characterized as potent, orally effective and long-acting antiplatelet/antithrombotic agent

Read More

Targeted Genetics, Sangamo combine two novel technologies for drug discovery

Read More

La Jolla reports progress on three fronts at H&Q conference

Read More

InKine investigates Syk kinase inhibitors for asthma, other inflammatory conditions

Read More

Watson completes TheraTech acquisition

Read More

Knoll's antiobesity drug Reductil approved in Germany

Read More

Relationship between antitumor activity of bombesin/GRP antagonists and effects on EGF receptors

Read More

Antiidiotype MAb in development by Immune Network Research receives patent coverage

Read More

Besins Iscovesco provides funds to speed development of Andractim

Read More

LeukoSite, Warner-Lambert collaborate on integrin antagonist research

Read More

Takeda submits NDA for type II diabetes treatment

Read More

Dose of O6-benzylguanine for use with BCNU in brain cancer patients determined

Read More

Cell Pathways explores SAANDs as new class of anticancer drugs; patent issues in U.S.

Read More

Allelix: Q1 1999 highlights

Read More

Oral heparin shown equivalent in efficacy and safety to injectable heparin

Read More

New neurological and immunological therapies basis of Neurocrine Biosciences-Caliper collaboration

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 4, 2025.
  • Today's news in brief

    Briefs
    BioWorld MedTech briefs for Jan. 30, 2026.
  • Art concept for medical research

    MicroRNAs in circulating extracellular vesicles as IPF biomarkers

    BioWorld Science
    MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
  • Brain illustration

    MJFF grant supports Bexorg’s translational biomarker work

    BioWorld Science
    Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
  • Brain and DNA

    REST emerges as biomarker in ALS, knockdown improves ALS symptoms

    BioWorld Science
    About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing